ADMI welcomes the government's decision to maintain stringent clinical trial requirements for In-Vitro Diagnostics (IVDs), reinforcing the commitment to safety and efficacy in India’s healthcare sector. By refusing to waive clinical trials for IVDs approved in other developed countries, the government ensures that these devices